HomeopathyPub Date : 2024-02-01Epub Date: 2023-09-06DOI: 10.1055/s-0043-1770339
Somasundaram Arumugam, Kumaravel Vadivel, Devendra Kumar Dhaked, Vani Sai Prasanna, Manoj Limbraj Yellurkar, Pamelika Das, Raja Manoharan, Austin Jose Thomas, Lalith Singh, Subhas Singh, Ravichandiran Velayutham
{"title":"Antiviral Activity of Cinchona officinalis, a Homeopathic Medicine, against COVID-19.","authors":"Somasundaram Arumugam, Kumaravel Vadivel, Devendra Kumar Dhaked, Vani Sai Prasanna, Manoj Limbraj Yellurkar, Pamelika Das, Raja Manoharan, Austin Jose Thomas, Lalith Singh, Subhas Singh, Ravichandiran Velayutham","doi":"10.1055/s-0043-1770339","DOIUrl":"10.1055/s-0043-1770339","url":null,"abstract":"<p><strong>Background: </strong>Coronavirus disease 2019 (COVID-19) is a potentially fatal disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several studies have shown that hydroxychloroquine (HCQ) significantly inhibits SARS-CoV-2 infections <i>in vitro</i>.</p><p><strong>Objective: </strong>Since the phytoconstituents of <i>Cinchona officinalis</i> (CO) are similar to those of HCQ, the objective of this study was to test the antiviral potential of different homeopathic formulations of CO.</p><p><strong>Methods: </strong>An analysis of the molecular composition of CO was carried out using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry, followed by a detailed docking study. The constituents of CO were docked against various targets of SARS-CoV-2, and the binding potential of the phytoconstituents was compared and quantified. The ligand with the lowest Glide docking score is considered to have the best binding affinity. The cytotoxicity of several homeopathic formulations, including CO mother tincture (CO-MT), was also checked on VeroE6 cells. A known antiviral, remdesivir, was used as a positive control for the <i>in vitro</i> assays to evaluate the effects of CO-MT against SARS-CoV-2-infected VeroE6 cells.</p><p><strong>Results: </strong>Molecular docking studies showed that constituents of CO exhibited binding potential to various targets of SARS-CoV-2, including Mpro, PLpro, RdRp, nucleocapsid protein, ACE2 (in host) and spike protein. Quinoline, one of the constituents of CO, can potentially bind the spike protein of SARS-CoV-2. Quinic acid showed better binding capabilities with Mpro, PLpro RdRp, nucleocapsid protein and ACE2 (allosteric site) than other constituents. Quinidine exhibited better binding to ACE2. Compared to HCQ, other phytoconstituents of CO had the equivalent potential to bind the RNA-dependent RNA polymerase, nucleocapsid protein, Mpro, PLpro and spike protein of SARS-CoV-2. <i>In vitro</i> assays showed that homeopathic CO-MT was not cytotoxic and that CO-MT and remdesivir respectively caused 89% and 99% inhibition of SARS-CoV-2 infection in VeroE6 cells.</p><p><strong>Conclusion: </strong>Based on this <i>in silico</i> and <i>in vitro</i> evidence, we propose CO-MT as a promising antiviral medicine candidate for treating COVID-19. <i>In vivo</i> investigation is required to clarify the therapeutic potential of CO-MT in COVID-19.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"16-24"},"PeriodicalIF":1.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10167461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2024-02-01Epub Date: 2023-07-05DOI: 10.1055/s-0043-1768465
Bruna de Fatima Antunes Laginestra, Thaís Camaso de Sá, Jessé Lahos Borges, Matheus Basilio Marçal, João Vitor Morais Simões, Selma Alves Rodrigues, Zilda Cristiani Gazim, Ranulfo Piau Júnior
{"title":"Impact of a Novel Homeopathic Complex Medicine on the Management of Multiple Antibiotic-Resistant Bovine Mastitis: An Open-Label, Non-Randomized, Placebo-Controlled Trial.","authors":"Bruna de Fatima Antunes Laginestra, Thaís Camaso de Sá, Jessé Lahos Borges, Matheus Basilio Marçal, João Vitor Morais Simões, Selma Alves Rodrigues, Zilda Cristiani Gazim, Ranulfo Piau Júnior","doi":"10.1055/s-0043-1768465","DOIUrl":"10.1055/s-0043-1768465","url":null,"abstract":"<p><strong>Background: </strong>Bovine mastitis is characterized by an inflammatory process in the mammary gland and represents one of the main diseases affecting a dairy herd. Management of mastitis is most commonly via antibiotics, but the rising incidence of multiple antibiotic resistance (MAR) means that additional options are needed. Homeopathic products can be administered in dairy farming for a range of clinical reasons and may be preferential due to the absence of residues.</p><p><strong>Objectives: </strong>The aim of this study was to assess the potential of a novel homeopathic complex medicine in managing bovine mastitis.</p><p><strong>Methods: </strong>Twenty-four lactating Holstein cows with mastitis were divided into two groups: the homeopathic complex group received a homeopathic complex daily for 60 days at a dose of 20 g/d; the placebo group received the calcium carbonate vehicle without homeopathic medicines at the same dose and repetition. The main outcome measure was somatic cell count (SCC; cells/mL), with additional outcome measures including milk production (kg/d), milk constituents (percentage of protein, fat, lactose and total milk solids), and serum levels of cortisol, glucose, ammonia and lactic acid. All outcomes were measured at the beginning of the study and after 30 and 60 days. Milk samples were also collected from all animals at the beginning of the study, confirming a high (>0.2) MAR index for isolated bacterial cultures.</p><p><strong>Results: </strong>Assessment of SCC showed a statistically significant difference favoring the homeopathic complex versus placebo group at day 60. A reduction in serum cortisol levels and an increase in fat, lactose and total milk solids in animals treated with the homeopathic complex at day 60 were also seen. Other outcome measures did not show statistically significant inter-group differences.</p><p><strong>Conclusion: </strong>The results of this non-randomized, open-label, placebo-controlled trial suggest the potential for a novel homeopathic complex medicine in management of multiple antibiotic-resistant bovine mastitis, thus offering dairy farmers an additional option to antibiotics and making dairy products safer for consumer health and milk production more sustainable.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"25-31"},"PeriodicalIF":1.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10114382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2024-02-01Epub Date: 2024-01-29DOI: 10.1055/s-0043-1777309
E Rachel Roberts, Angelina J Mosley, Alexander L Tournier
{"title":"Insights from a Decade of 'Cutting Edge Research in Homeopathy'.","authors":"E Rachel Roberts, Angelina J Mosley, Alexander L Tournier","doi":"10.1055/s-0043-1777309","DOIUrl":"10.1055/s-0043-1777309","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"113 1","pages":"1-3"},"PeriodicalIF":1.2,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139575595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2023-12-29DOI: 10.1055/s-0043-1776758
{"title":"Homeopathic Medicines in Third (Omicron) Wave of COVID-19: Prognostic Factor Research","authors":"","doi":"10.1055/s-0043-1776758","DOIUrl":"https://doi.org/10.1055/s-0043-1776758","url":null,"abstract":"Background With the emergence of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, such as the Omicron variant, during the third wave of the coronavirus disease 2019 (COVID-19) pandemic, there was a need to identify useful homeopathic medicines. This study aimed to identify such medicines and their indications using prognostic factor research (PFR). Methods This was an open-label, multi-centred observational study conducted in January 2022, on confirmed COVID-19 cases. The data were collected from integrated COVID Care Centres in Delhi, India, where homeopathic medicines were prescribed along with conventional treatment. Only those cases that met a set of selection criteria were considered for analysis. The likelihood ratio (LR) was calculated for the frequently occurring symptoms of the frequently prescribed medicines. An LR of 1.3 or greater was considered meaningful. Results Out of the 362 COVID-19 cases, 263 cases were selected for analysis after applying selection criteria. Common symptoms included fatigue, cough, sore throat, myalgia and headache. Twenty-one medicines were prescribed, of which nine medicines – Gelsemium sempervirens, Bryonia alba, Hepar sulphuris, Rhus toxicodendron, Pulsatilla nigricans, Arsenicum album, Belladonna, Nux vomica and Phosphorus – were frequently used. By calculating LRs, the study identified meaningful indications for these medicines. Conclusion Homeopathic medicines have shown promising results in the third wave of COVID-19 as an adjunct therapy. The medicines that were used in the first and second waves were found useful in the third wave also, and their indications were analogous to those found in the earlier waves. Certain new indications of some medicines were elicited in this wave, which warrant further research. However, it is important not to restrict to these medicines only and to continue data collection on COVID-19 in future waves for the improvement of the COVID-19 mini-repertory.","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"1 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139068125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2023-12-13DOI: 10.1055/s-0043-1776024
Steven J. Cartwright, Tony S. Pinkus
{"title":"Evidence from the Use of Solvatochromic Dyes Indicates that Bulk Pure Water does not Potentise","authors":"Steven J. Cartwright, Tony S. Pinkus","doi":"10.1055/s-0043-1776024","DOIUrl":"https://doi.org/10.1055/s-0043-1776024","url":null,"abstract":"<p>\u0000<b>Background</b> Whilst it is assumed that water plays a crucial role in homeopathy, it is unclear what specific functions water has in the generation, propagation and maintenance of homeopathic potencies. Solvatochromic dyes have demonstrated themselves to be reliable indicators of the presence of potencies and so are well placed to begin to address these questions.</p> <p>\u0000<b>Objective</b> The aim of the current study was to ascertain whether pure water could be potentised. If pure water can be potentised, this would indicate that water plays a crucial role in the generation of homeopathic potencies. If it cannot be potentised, then this result points to water being an inert carrier and medium for the potentisation of substances placed in it.</p> <p>\u0000<b>Methods</b> A specially designed potentiser capable of consistently and reliably producing homeopathic potencies to rigorous standards (Pinkus Potentiser) was used to run up potencies of “Water 10M” and <i>Arsenicum</i> 10M in two interchangeable stainless-steel vials. “Water 10M” and <i>Arsenicum</i> 10M, along with unsuccussed control water, were then tested against solutions of the solvatochromic dye phenol blue by following the absorbance of the dye at 658 nm.</p> <p>\u0000<b>Results “</b>Water 10M” gave results no different statistically from unsuccussed water (<i>p</i> > 0.05) with no change over the time course of the experiments, whereas <i>Arsenicum</i> 10M gave statistically different results (<i>p</i> < 0.001) with increasing divergence from both “Water 10M” and unsuccussed water over time. Similar results were obtained when the vials in which <i>Arsenicum</i> 10M and “Water 10M” were produced were exchanged, so that the vial in which <i>Arsenicum</i> 10M had been produced was then used to produce “Water 10M” and vice versa, indicating the results could not be explained by any anomalies in the production vials themselves.</p> <p>\u0000<b>Conclusion</b> Results using the solvatochromic dye phenol blue to detect and measure homeopathic potencies indicate that bulk water itself does not potentise and that unsuccussed water and water that has been succussed are no different. This indicates that what is potentised during cycles of dilution and succussion are the substances placed in water and not the water itself. In turn, this indicates that water is simply a carrier for the homeopathic signal. Evidence from the practice of homeopathy supports this conclusion.</p> ","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"176 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138628233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Stem Cell Secretome Modulated by Arsenicum album 30C Ameliorates Lipopolysaccharide-induced Cytokine Storm in Blood Mononuclear Cells in vitro","authors":"Parth Aphale, Avinash Sanap, Dharmendra Sharma, Avinash Kharat, Supriya Kheur, Chinmay Gawade, Indumati Somasundaram, Ramesh Bhonde","doi":"10.1055/s-0043-1776039","DOIUrl":"https://doi.org/10.1055/s-0043-1776039","url":null,"abstract":"<p>\u0000<b>Background</b> The therapeutic effectiveness of mesenchymal stem cells (MSCs) and their secretome can be enhanced by means of physical, chemical and biological preconditioning. <i>Arsenicum album</i> 30C (AA30) has been one of the leading homeopathic medicines used in prophylaxis against SARS-CoV-2 infection.</p> <p>\u0000<b>Aims</b> This study aimed to investigate whether AA30 preconditioning could influence the growth factors and cytokine profile of the human dental pulp-derived MSC (DPD-MSC) secretome. Also, to test the efficacy of the AA30-preconditioned DPD-MSC secretome in ameliorating the lipopolysaccharide (LPS)-induced cytokine storm in human peripheral blood mononuclear cells (PBMCs) as an <i>in-vitro</i> cellular model.</p> <p>\u0000<b>Methods</b> The cytotoxicity of AA30 was assessed in DPD-MSCs by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Growth factors and cytokine levels in the AA30-preconditioned DPD-MSC secretome were analysed by fluorescence-activated cell sorting (FACS) analysis. The angiogenic potential of the AA30-preconditioned DPD-MSC secretome was assessed by chick yolk-sac membrane (YSM) assay. Culture medium with 0.001% ethanol was used as vehicle control. The efficacy of the AA30-preconditioned DPD-MSC secretome in ameliorating the cytokine storm was assessed in LPS pre-treated PBMCs. The mRNA and protein expression of inflammatory markers such as IL-1β, IL-6 and IL-10 were analysed by using RT-PCR and FACS analysis respectively.</p> <p>\u0000<b>Results</b> AA30 did not exhibit cytotoxicity in the concentration range of 1% to 50%. Furthermore, the AA30-preconditioned DPD-MSC secretome exhibited a significant increase in the levels of angiogenic factors, such as human angiopoietin-2, EPO and PDGF-AA, and decreased levels of cytokines, such as TNF-α, CXCL-8 and IL-6. The AA30-preconditioned DPD-MSC secretome showed augmented angiogenesis compared to vehicle controls. The DPD-MSC secretome ameliorated LPS-induced mRNA and protein expression of IL-1β, IL-6 and IL-10 in PBMCs.</p> <p>\u0000<b>Conclusion</b> The AA30-preconditioned DPD-MSC secretome augmented angiogenesis and ameliorated the LPS-induced cytokine storm in human PBMCs <i>in vitro</i>. Our data demonstrate that AA30 preconditioning enhances the therapeutic potency of MSCs and their secretome.</p> ","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"9 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138555440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Role of Prophylactic Dose of Oral Amoxicillin Trihydrate in Prevention of Bacteremia Post Surgical Removal of Impacted Mandibular Third Molar: A Clinical Study.","authors":"Vikrant Dilip Sane, Abhijeet Ranade, Vivek Sunil Nair, Rashmi Vikrant Sane, Pankaj Kadam, Nishita Bhosale","doi":"10.1007/s12070-023-03883-2","DOIUrl":"10.1007/s12070-023-03883-2","url":null,"abstract":"<p><p>The current study is designed to evaluate the efficacy of pre-operative prophylactic antibiotic for prevention of bacteremia after surgical removal of impacted mandibular third molar SRIMTM. The study was carried out as an open clinical trial. Fifty patients who fulfilled the criteria were included. Twenty five randomly selected patients (study group) were administered two grams oral dose of amoxicillin trihydrate, one hour prior to the procedure. Twenty five patients (control group) were not administered any antibiotic prior to the procedure. All patients underwent surgical removal of impacted mandibular third molar through intraoral approach under local anesthesia. Blood culture for detection of aerobic and anaerobic micro-organisms was done for all 50 patients. Eleven out of the twenty five patients (44%) in the control group showed positive growth, including mixed growth (aerobic and anaerobic). Seven patients showed purely anaerobic, 2 patients purely aerobic and two mixed growth. In the study (antibiotic) group, 7 out of the 25 patients (28%) showed positive growth, including mixed growth. Three patients showed purely anaerobic, 2 patients purely aerobic and 2 mixed type of growth. The study suggests that the judicious use of antibiotic prophylaxis, in conjunction with optimal oral health care serves to minimize the adverse effects of antibiotic therapy; and at the same time reduce the significant morbidity and mortality associated with systemic infections that might occur due to bacteremia resulting from surgical procedures of the oral cavity.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"79 1","pages":"2907-2912"},"PeriodicalIF":1.2,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77745311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HomeopathyPub Date : 2023-11-01Epub Date: 2023-03-16DOI: 10.1055/s-0043-1760845
Petra Weiermayer, Michael Frass, Philippa Fibert, Christien Klein-Laansma, Susanne Ulbrich-Zürni
{"title":"Recommendations for Designing, Conducting and Reporting Clinical Observational Studies in Homeopathic Veterinary Medicine.","authors":"Petra Weiermayer, Michael Frass, Philippa Fibert, Christien Klein-Laansma, Susanne Ulbrich-Zürni","doi":"10.1055/s-0043-1760845","DOIUrl":"10.1055/s-0043-1760845","url":null,"abstract":"<p><strong>Background: </strong>Clinical observational studies are an important methodological approach in human and veterinary research, examining and describing treatment experience with good external validity. There are currently few observational studies in the field of homeopathic veterinary medicine.</p><p><strong>Aim: </strong>The aim of the study was to develop recommendations for designing, conducting and reporting observational studies in homeopathic veterinary medicine.</p><p><strong>Materials and methods: </strong>A literature review was performed using various search strategies for identifying guidelines and checklist tools relevant for observational studies, veterinary research and homeopathy. Useful guidelines were selected. Prior recommendations for designing and conducting observational studies in human homeopathic medicine were supplemented with recommendations for homeopathic veterinary medicine that were evaluated by an expert panel.</p><p><strong>Results: </strong>The veterinary extension of the Strengthening the Reporting of Observational Studies in Epidemiology - Veterinary (STROBE-Vet) statement was identified as a useful tool to improve the reporting quality of observational studies, and it has been supplemented here with additional recommendations that are applicable to homeopathy. STROBE-Vet is complemented in the literature by several reports, checklists and guidelines on veterinary medicine in general, such as the Checklist for One Health Epidemiological Reporting of Evidence (COHERE) and the Animal Health Surveillance Reporting Guidelines (AHSURED). Identified items that related to laboratory animal research were excluded as non-relevant to our study.</p><p><strong>Conclusion: </strong>Clinical observational studies are an important methodological approach, having currently unrealized potential in the field of homeopathic veterinary medicine. With relatively minor adjustments, the practical guidelines and checklists available to researchers in designing, conducting and reporting observational studies in human homeopathic medicine have been adapted for homeopathic veterinary medicine, for which high quality can be assured by implementing recommendations such as those in STROBE-Vet. With the emergence of the One Health concept, the COHERE checklist can be viewed with growing significance.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"226-239"},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/e4/10-1055-s-0043-1760845.PMC10586889.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9122594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Evaluation of Therapeutic Potential of Selected Plant-Derived Homeopathic Medicines for their Action against Cervical Cancer.","authors":"Tejveer Singh, Nikita Aggarwal, Kulbhushan Thakur, Arun Chhokar, Joni Yadav, Tanya Tripathi, Mohit Jadli, Anjali Bhat, Arun Kumar, Ritika Hasija Narula, Pankaj Gupta, Anil Khurana, Alok Chandra Bharti","doi":"10.1055/s-0042-1756436","DOIUrl":"10.1055/s-0042-1756436","url":null,"abstract":"<p><strong>Background: </strong>Plant-derived homeopathic medicines (HMs) are cheap and commercially available but are mechanistically less explored entities than conventional medicines.</p><p><strong>Purpose: </strong>The aim of our study was to evaluate the impact of selected plant-derived HMs derived from <i>Berberis aquifolium</i> (BA)<i>, Berberis vulgaris</i> (BV), <i>Mentha piperita</i> (MP), <i>Curcuma longa</i> (CL), <i>Cinchona officinalis</i> (CO), <i>Thuja occidentalis</i> (TO) and <i>Hydrastis canadensis</i> (HC) on cervical cancer (CaCx) cells <i>in vitro</i>.</p><p><strong>Methods: </strong>We screened the mother tincture (MT) and 30C potencies of the above-mentioned HMs for anti-proliferative and cytotoxic activity on human papillomavirus (HPV)-negative (C33a) and HPV-positive CaCx cells (SiHa and HeLa) by MTT assay. Total phenolic content (TPC) and the free-radical scavenging activity of each HM was also determined using standard assays. Phytochemicals reportedly available in these HMs were examined for their potential inhibitory action on HPV16 E6 by <i>in silico</i> molecular docking.</p><p><strong>Results: </strong>All tested MTs induced a differential dose-dependent cytotoxic response that varied with cell line. For C33a cells, the order of response was TO > CL > BA > BV > HC > MP > CO, whereas for SiHa and HeLa cells the order was HC > MP > TO > CO > BA > BV > CL and CL > BA > CO, respectively. 30C potencies of all HMs showed an inconsistent response. Further, anti-CaCx responses displayed by MTs did not follow the order of an HM's phenolic content or free radical scavenging activity. Analysis revealed anti-oxidant content of BA, BV and HC had the lowest contribution to their anti-CaCx activity. Using <i>in silico</i> modeling of molecular docking between the HPV16 E6 protein crystallographic structures (6SJA and 4XR8) and main phytochemical components of BV, BA, HC, CL and TO, their potential to inhibit the HPV16 E6 protein carcinogenic interactions was identified.</p><p><strong>Conclusion: </strong>The study has shown a comparative evaluation of the potential of several plant-derived MTs and HMs to affect CaCx cell line survival <i>in vitro</i> (through cytotoxicity and free radical scavenging) and their theoretical molecular targets <i>in silico</i> for the first time. Data demonstrated that MTs of BA and BV are likely to be the most potent HMs that strongly inhibited CaCx growth and have a strong anti-HPV phytochemical constitution.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":" ","pages":"262-274"},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10804931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}